Sumitomo Pharma shares received an improved outlook from Jefferies as analyst Stephen Barker upgraded the company's stock rating from Hold to Buy, accompanied by a price target increase to JPY900 from ...

Noble Capital Markets has recently initiated Tonix Pharmaceuticals Holding Corp (TNXP) stock to Outperform rating, as announced on April 18, 2022, according to Finviz. Earlier, on April 18, 2019, ROTH ...

Subin Baral, EY global life sciences deals leader, told GEN M&A deals are expected to increase in 2025, driven by biopharmas that are eager to recoup revenues they expect to lose as their aging ...

MedPlus Health Services is prioritizing private label growth, as a 1% increase in sales from this segment raises overall margins by 0.4% to 0.5%.

As per provisional closing, the S&P BSE Sensex, declined 319.22 points or 0.41% to 77,186.74. The Nifty 50 index lost 121.10 points or 0.52% to 23,361.05.

As per provisional closing, the S&P BSE Sensex, declined 319.22 points or 0.41% to 77,186.74. The Nifty 50 index lost 121.10 points or 0.52% to 23,361.05.

Move coincides with Trump's tariff threat to bring semiconductor, chip and pharmaceutical production back to US - Anadolu ...

Pharmaceutical companies make drugs and vaccines ... Both licenses allow Knight to earn a portion of the drugs’ sales. The company has licenses for over 100 products and has strong positive ...

Forecast issued at 4:30 pm EDT on Sunday 2 February 2025.